Among inflammatory markers, IL6 is the main candidate to be considered as an indicator of plaque progression, whereas there is a lack of evidence concerning other cytokines and the risk of atherosclerosis progression in patients with carotid stenosis or ischemic stroke. Here, IL6 is linked to ischemic stroke.